Education
About Us
Working with TipRanks
Follow Us
Glucotrack, Inc. (GCTK)
:GCTK
GCTK Stock Chart & Stats
Day’s Range― - ―
52-Week Range$5.16 - $3,756.00
Previous Close$0.14
Volume195.77M
Average Volume (3M)75.39K
Market Cap
$4.45M
Enterprise Value$2.18B
Total Cash (Recent Filing)$9.10M
Total Debt (Recent Filing)$52.00K
Price to Earnings (P/E)―
Beta1.10
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-68.06
Shares Outstanding567,456
10 Day Avg. Volume122,228
30 Day Avg. Volume75,395
Financial Highlights & Ratios
PEG Ratio-66.37
Price to Book (P/B)1.77K
Price to Sales (P/S)0.00
P/FCF Ratio-584.97
Enterprise Value/Market Cap489.97
Enterprise Value/Revenue25.95K
Enterprise Value/Gross Profit-272.48K
Enterprise Value/Ebitda-34.23
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
GlucoTrack News
Options Prices
Currently, No data available
---
Ownership Overview
25.79% Insiders
<0.01%
Mutual Funds
0.18% Other Institutional Investors
74.02% Public Companies and Individual Investors
GCTK FAQ
What was Glucotrack, Inc.’s price range in the past 12 months?
Glucotrack, Inc. lowest stock price was $5.16 and its highest was $3756.00 in the past 12 months.
What is Glucotrack, Inc.’s market cap?
Glucotrack, Inc.’s market cap is $4.45M.
When is Glucotrack, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Glucotrack, Inc.’s earnings last quarter?
Glucotrack, Inc. released its earnings results on Mar 31, 2025. The company reported -$40.349 earnings per share for the quarter, missing the consensus estimate of N/A by -$40.349.
Is Glucotrack, Inc. overvalued?
According to Wall Street analysts Glucotrack, Inc.’s price is currently Overvalued.
Does Glucotrack, Inc. pay dividends?
Glucotrack, Inc. does not currently pay dividends.
What is Glucotrack, Inc.’s EPS estimate?
Glucotrack, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Glucotrack, Inc. have?
Glucotrack, Inc. has 567,456 shares outstanding.
What happened to Glucotrack, Inc.’s price movement after its last earnings report?
Glucotrack, Inc. reported an EPS of -$40.349 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 0.111%.
Which hedge fund is a major shareholder of Glucotrack, Inc.?
Currently, no hedge funds are holding shares in GCTK
GlucoTrack Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Insider Transactions
Bought Shares
Worth $301.3K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 4.0%
Last 30 Days ▼ 1.6%
Last 30 Days ▼ 1.6%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-99.68%
12-Months-Change
Fundamentals
Return on Equity
-694.34%
Trailing 12-Months
Asset Growth
356.41%
Trailing 12-Months
Company Description
Glucotrack, Inc.
GlucoTrack, Inc., a medical device company, designs, develops, and commercializes non-invasive glucose monitoring devices for use by people suffering from diabetes and pre-diabetics in Israel and internationally. It develops GlucoTrack glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Or Yehuda, Israel.
Technical Analysis
Milestone Scientific
―
Predictive Oncology
―
Femasys
―
Meihua International Medical Technologies Co., Ltd.
―
Sharps Technology, Inc.
―